Consensus Valneva

Equities

VLA

FR0004056851

Biotechnology & Medical Research

Market Closed - Euronext Paris Other stock markets 16:55:00 13/02/2026 GMT			5-day change	1st Jan Change
4.338 ^EUR	-0.18%		+7.70%	+16.68%

02-13	Valneva SE Provides Update on Recommendations for Use of IXCHIQ in the United Kingdom	CI
02-13	Valneva, Rubis, Groupe DLSI... Stocks to Watch on Monday in Paris

Evolution of the Average Target: Valneva

Evolution of the Target Price: Valneva

Changes in Analyst Recommendations: Valneva

7ce1c26da6a988d8be24.k6Dtq6C_tBAUsXrpX7AiFmBJtP3nUQWRhPrM15Ao7ho.3JPcnfCL-3598AyvLsZxfRkahJu1aVahzpGmpadmplSmkdvf6evbRm3oQg~6855b98e39d61cc1f1f8acf53a82d388

Analysts' recommendations: Valneva

01-20	Stifel Reiterates Buy Rating and Price Target on Valneva
01-06	Valneva, Biggest Gainer on SBF 120 and SRD at Close of Tuesday, January 6, 2026
01-06	Valneva Surges on Positive Broker Comments
01-06	CAC 40 Lags Behind; Valneva in Demand
01-06	Valneva Posts Strongest Midday Gain on SBF 120, Tuesday, January 6, 2026
01-06	Stock of the Day in Paris – Valneva Bolstered by Stifel
01-06	Stifel Raises Price Target for Valneva
11-20	Stifel Reiterates Buy Recommendation on Valneva
11-04	Valneva SE Announces Positive Results of Its Phase 1 Clinical Trial Investigating the Safety and Immunogenicity of VLA1601	CI
03/09/25	Valneva publishes positive data for its Lyme disease vaccine candidate, stock rises	RE
26/08/25	Valneva: Stifel Adjusts Price Target Following FDA Suspension of Ixchiq License
26/08/25	Valneva: Stifel adjusts target price
12/08/25	Valneva: Oddo BHF confirms 'outperform' rating
14/07/25	Valneva Shares Surge After EMA Lifts Restriction on Chikungunya Vaccine	RE
13/08/24	Valneva: share price up, broker's analysis
13/08/24	Valneva: Oddo BHF confirms its recommendation on the stock
24/06/24	Valneva rises after Canadian approval for its chikungunya vaccine	RE
05/02/24	Valneva: Oddo BHF confirms its recommendation on the stock
02/01/24	Valneva: Oddo BHF remains positive
10/11/23	HC Wainwright Adjusts Price Target on Valneva SE to $26 From $22, Maintains Buy Rating	MT
08/11/23	Valneva: share price in demand on eve of earnings release
14/08/23	Valneva falls after FDA postpones review date for its Chikungunya vaccine	RE
16/06/23	Valneva: up sharply after positive analysis
16/06/23	Valneva: one of Oddo BHF's favorite European biotechs
01/10/22	HC Wainwright Adjusts Price Target on Valneva to $27 From $32, Reiterates Buy Rating	MT